Steven Yatomi-Clarke
Steven Yatomi-Clarke is the CEO & Managing Director of Prescient Therapeutics, a clinical stage company developing cellular and targeted therapies against various cancers.
At Prescient, Steven manages a team in Australia and the US and has been instrumental in strategy development; initiating and managing clinical trials; fundraising and business development.
Previously, Steven had a distinguished career as an investment banker specialising in the life sciences sector, where he was consistently one of the country’s most prolific bankers, involved in primary and secondary offerings, corporate advisory and M&A assignments. In particular, Steven leveraged his combined backgrounds in science and finance to identify undervalued and unlikely opportunities and structure deals for the mutual benefit of companies and investors.
Steven holds a Bachelor of Science with an Honours Degree in Biochemistry and Molecular Biology, and a Bachelor Commerce majoring in Economics, both from the University of Melbourne.
Abstracts this author is presenting: